Table 2 Anesthesia, operation and pathological data
From: Risk factors of prolonged ventilation after thymectomy in thymoma myasthenia gravis patients
Parameter | Group 1 (n = 74) | Group 2 (n = 38) | Z/χ2 | P value |
|---|---|---|---|---|
Anesthesia method, n (%) | ||||
Intravenous-inhalational anesthesia | 46 (62.2) | 22 (57.9) | 0.192 | 0.662 |
Total intravenous anesthesia | 28 (37.8) | 16 (42.1) | ||
Nondepolarizing NMBAs | 69 (93.2) | 35 (92.1) | 0.000 | 1.000 |
Muscle relaxant antagonist | 29 (39.2) | 3 (7.9) | 12.048 | 0.001 |
Surgical procedure, n (%) | ||||
VATS, n (%) | 69 (93.2) | 27 (71.1) | 10.097 | 0.001 |
OT | 5 (6.8) | 11 (28.9) | ||
Phrenic never or diaphragm injury, n (%) | 14 (18.9) | 15 (39.5) | 5.528 | 0.019 |
Vasoactive agents, n (%) | 31 (41.9) | 17 (44.7) | 0.083 | 0.773 |
Plumonary wedge resection | 7 (9.5) | 9 (23.7) | 4.149 | 0.042 |
Pericardiotomy | 13 (17.6) | 16 (42.1) | 7.878 | 0.005 |
Operative blood loss(ml), M (p25, p75) | 50 (20, 100) | 100 (50, 300) | − 3.807 | < 0.001 |
Operation time (min), M (p25, p75) | 140 (110, 180) | 200 (148, 280) | − 4.135 | < 0.001 |